Allied Corp. Strengthens National Brand Support with the Signing of Elite Athlete David Lipson

    NEXT STORY
    Taconic Biosciences Expands Innovative ExpressMODEL® Portfolio
    PREV STORY
    Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
    Subscribe to PM360
    Print Subscription
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Phase 2 CoDIFy Trial Results Published in Lancet Infectious Diseases With Data Showing Summit’s Ridinilazole Achieved Statistical Superiority over Vancomycin in the Treatment of C. Difficile Infection

    OXFORD, United Kingdom, April 28, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the ...

    author_avatar
    NASDAQ Market News

    Novartis Kisqali® received FDA Breakthrough Therapy designation for initial endocrine-based treatment in premenopausal women with HR+/HER2- advanced breast cancer

    Designation based on Phase III MONALEESA-7 results demonstrating superior efficacy of Kisqali in combination ...

    author_avatar
    NASDAQ Market News

    Roche confirms US government agreement to purchase additional doses of Regeneron’s casirivimab and imdevimab

    author_avatar
    NASDAQ Market News